FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ralf Wilkowski

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Michael Staehler; Christian G Stief; Nikolas Haseke; Philipp Nuhn; Alexander Roosen; Thomas Stadler; Ralf Wilkowski
Feasibility and effects of high-dose hypofractionated radiation therapy and simultaneous multi-kinase inhibition with sunitinib in progressive metastatic renal cell cancer.
Andreas Rank; Bettina Toth; Ralf Wilkowski; Verena Pihusch; Ruth Delker; Hans-Jochem Kolb; Rienk Nieuwland; Rudolf Pihusch
Surveillance of megakaryocytic function by measurement of CD61-exposing microparticles in allogeneic hematopoietic stem cell recipients.
Andreas Rank; Rienk Nieuwland; Ruth Delker; Anton Köhler; Bettina Toth; Verena Pihusch; Ralf Wilkowski; Rudolf Pihusch
Cellular origin of platelet-derived microparticles in vivo.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ralf Wilkowski (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Michael Staehler; Christian G Stief; Nikolas Haseke; Philipp Nuhn; Alexander Roosen; Thomas Stadler; Ralf Wilkowski
Feasibility and effects of high-dose hypofractionated radiation therapy and simultaneous multi-kinase inhibition with sunitinib in progressive metastatic renal cell cancer.
Urologic oncology 2012;30(3):290-3.
2011: Andreas Rank; Bettina Toth; Ralf Wilkowski; Verena Pihusch; Ruth Delker; Hans-Jochem Kolb; Rienk Nieuwland; Rudolf Pihusch
Surveillance of megakaryocytic function by measurement of CD61-exposing microparticles in allogeneic hematopoietic stem cell recipients.
Clinical transplantation 2011;25(3):E233-42.
2010: Andreas Rank; Rienk Nieuwland; Ruth Delker; Anton Köhler; Bettina Toth; Verena Pihusch; Ralf Wilkowski; Rudolf Pihusch
Cellular origin of platelet-derived microparticles in vivo.
Thrombosis research 2010;126(4):e255-9.
2010: Michael Haas; Rüdiger P Laubender; Petra Stieber; Stefan Holdenrieder; Christiane J Bruns; Ralf Wilkowski; Ulrich Mansmann; Volker Heinemann; Stefan Boeck
Prognostic relevance of CA 19-9, CEA, CRP, and LDH kinetics in patients treated with palliative second-line therapy for advanced pancreatic cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2010;31(4):351-7.
2010: F T Kolligs; Ralf-Thorsten Hoffmann; M op den Winkel; C J Bruns; K Herrmann; T F Jakobs; R Lamerz; Christoph Trumm; Christoph J Zech; Ralf Wilkowski; Christian Graeb
[Diagnosis and multimodal therapy for hepatocellular carcinoma].
Zeitschrift für Gastroenterologie 2010;48(2):274-88.
2008: Stefan Holdenrieder; Dorothea Nagel; Andreas Schalhorn; Volker Heinemann; Ralf Wilkowski; Joachim von Pawel; Hannelore Raith; Knut Feldmann; Andreas E. Kremer; Susanne Müller; Sandra Geiger; Gerhard F Hamann; Dietrich Seidel; Petra Stieber
Clinical relevance of circulating nucleosomes in cancer.
Annals of the New York Academy of Sciences 2008;1137():180-9.
2008: Valeria Milani; Montserrat Pazos; Rolf Issels; Veit Buecklein; Sultan Rahman; Katharina Tschoep; Pamela Schaffer; Ralf Wilkowski; Eckhart Duehmke; Moshe Schaffer
Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2008;184(3):163-8.
2008: Philipp C Manegold; Carmen Paringer; Ulrike Kulka; Klaus Krimmel; Martin Eichhorn; Ralf Wilkowski; Karl-Walter Jauch; Markus Guba; Christiane J Bruns
Antiangiogenic therapy with mammalian target of rapamycin inhibitor RAD001 (Everolimus) increases radiosensitivity in solid cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(3):892-900.
2008: F T Kolligs; Christoph J Zech; S O Schönberg; Jörg Schirra; W Thasler; C Graeb; Ulrich Beuers; Ralf Wilkowski; T Jacobs; S Böck; J Berster; Volker Heinemann; C Schäfer
[Interdisciplinary diagnosis of and therapy for cholangiocarcinoma].
Zeitschrift für Gastroenterologie 2008;46(1):58-68.
2008: Ralf Wilkowski; M Wolf; V Heinemann
Primary advanced unresectable pancreatic cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2008;177():79-93.
2007: Stefan Boeck; Axel Hinke; Ralf Wilkowski; Volker Heinemann
Importance of performance status for treatment outcome in advanced pancreatic cancer.
World journal of gastroenterology : WJG 2007;13(2):224-7.
2007: Stefan Boeck; Ralf Wilkowski; Christiane J Bruns; Rolf Issels; Christoph Schulz; Nicolas Moosmann; Dorit Laessig; Michael Haas; Alexander Golf; Volker Heinemann
Oral capecitabine in gemcitabine-pretreated patients with advanced pancreatic cancer.
Oncology 2007;73(3-4):221-7.
2006: Moshe Schaffer; Birgit Ertl-Wagner; Pamela M Schaffer; Ulrike Kulka; Giulio Jori; Ralf Wilkowski; Alfons Hofstetter; Anton Hofstetter; Eckhart Dühmke
Feasibility of photofrin II as a radiosensitizing agent in solid tumors--preliminary results.
Onkologie 2006;29(11):514-9.
2006: Volker Heinemann; Detlef Quietzsch; Frank Gieseler; Michael Gonnermann; Herbert Schönekäs; Andreas Rost; Horst Neuhaus; Caroline Haag; Michael Clemens; Bernard Heinrich; Ursula Vehling-Kaiser; Martin Fuchs; Doris Fleckenstein; Wolfgang Gesierich; Dirk Uthgenannt; Hermann Einsele; Axel Holstege; Axel Hinke; Andreas Schalhorn; Ralf Wilkowski
Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(24):3946-52.
2006: Stefan Boeck; Petra Stieber; Stefan Holdenrieder; Ralf Wilkowski; Volker Heinemann
Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer.
Oncology 2006;70(4):255-64.
2006: Andreas E. Kremer; Stefan Holdenrieder; Petra Stieber; Ralf Wilkowski; Dorothea Nagel; Dietrich Seidel
Nucleosomes in colorectal cancer patients during radiochemotherapy.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2006;27(5):235-42.
2006: Ralf Wilkowski; Martin Thoma; Christiane Bruns; Andreas Wagner; Volker Heinemann
Chemoradiotherapy with gemcitabine and continuous 5-FU in patients with primary inoperable pancreatic cancer.
JOP : Journal of the pancreas 2006;7(4):349-60.
2006: Ralf Wilkowski; Martin Thoma; Christiane Bruns; Eckhart Dühmke; Volker Heinemann
Combined chemoradiotherapy for isolated local recurrence after primary resection of pancreatic cancer.
JOP : Journal of the pancreas 2006;7(1):34-40.
2005: Ralf Wilkowski; Sophia Pachmann; Beatrice Schymura; Marc Dellian; Andreas Schalhorn; Eckhart Dühmke
A new concurrent chemotherapy with vinorelbine and mitomycin C in combination with radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck.
Onkologie 2005;28(10):491-5.
2005: Ralf Wilkowski; Martin Thoma; Helmut Weingandt; Eckhart Dühmke; Volker Heinemann
Chemoradiation for ductal pancreatic carcinoma: principles of combining chemotherapy with radiation, definition of target volume and radiation dose.
JOP : Journal of the pancreas 2005;6(3):216-30.
2005: Andreas E. Kremer; Ralf Wilkowski; Stefan Holdenrieder; Dorothea Nagel; Petra Stieber; Dietrich Seidel
Nucleosomes in pancreatic cancer patients during radiochemotherapy.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2005;26(1):44-9.
2004: Ralf Wilkowski; Martin Thoma; Rolf Schauer; Andreas Wagner; Volker Heinemann
Effect of chemoradiotherapy with gemcitabine and cisplatin on locoregional control in patients with primary inoperable pancreatic cancer.
World journal of surgery 2004;28(10):1011-8.
2004: Ralf Wilkowski; Martin Thoma; Eckhart Dühmke; Horst G Rau; Volker Heinemann
Concurrent chemoradiotherapy with gemcitabine and cisplatin after incomplete (R1) resection of locally advanced pancreatic carcinoma.
International journal of radiation oncology, biology, physics 2004;58(3):768-72.
2003: J Stemmler; Petra Stieber; A M Szymala; Andreas Schalhorn; M M Schermuly; Ralf Wilkowski; T Helmberger; Rolf Lamerz; Clemens Stoffregen; K Niebler; M Garbrecht; Volker Heinemann
Are serial CA 19-9 kinetics helpful in predicting survival in patients with advanced or metastatic pancreatic cancer treated with gemcitabine and cisplatin?
Onkologie 2003;26(5):462-7.
2003: Matthias W Wichmann; Günther Meyer; Michaela Adam; Wilma Höchtlen-Vollmar; Martin K Angele; Andreas Schalhorn; Ralf Wilkowski; Christian Müller; Friedrich W Schildberg
Detrimental immunologic effects of preoperative chemoradiotherapy in advanced rectal cancer.
Diseases of the colon and rectum 2003;46(7):875-87.
2003: Ralf Wilkowski; Martin Thoma; Volker Heinemann; Horst G Rau; Andreas Wagner; Clemens Stoffregen; Eckhart Dühmke
[Radiochemotherapy with gemcitabine and cisplatin in pancreatic cancer -- feasible and effective].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2003;179(2):78-86.
2002: Moshe Schaffer; Martin Thoma; Ralf Wilkowski; Pamela Schaffer; Eckhart Dühmke
Radio-chemotherapy as a preoperative treatment for advanced rectal cancer. Evaluation of down-staging and morbidity.
Onkologie 2002;25(4):352-6.
2002: Horst G Rau; M W Wichmann; Ralf Wilkowski; Volker Heinemann; M Sackmann; T Helmberger; Eckhart Dühmke; Friedrich W Schildberg
[Surgical therapy of locally advanced and primary inoperable pancreatic carcinoma after neoadjuvant preoperative radiochemotherapy].
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 2002;73(2):132-7.
2002: Ralf Wilkowski; V Heinemann; Clemens Stoffregen
Gemcitabine (Gemzar) and radiotherapy--is it feasible?
Frontiers of radiation therapy and oncology 2002;37():78-83.
2001: Moshe Schaffer; Pamela M Schaffer; Monika Panzer; Ralf Wilkowski; Eckhart Dühmke
Porphyrias associated with malignant tumors: results of treatment with ionizing irradiation.
Onkologie 2001;24(2):170-2.
2000: Ralf Wilkowski; Volker Heinemann; H Rau
[Locally advanced pancreatic carcinoma. Radiochemotherapy prolongs survival].
MMW Fortschritte der Medizin 2000;142(42):31-2.
2000: M Busch; Ralf Wilkowski; M Schaffer; Eckhart Dühmke
Combined chemotherapy, radiotherapy, and immunotherapy for pancreatic carcinoma--a case report.
Advances in therapy 2000;17(3):133-9.
1999: Volker Heinemann; M M Schermuly; Petra Stieber; L Schulz; Dieter Jüngst; Ralf Wilkowski; Andreas Schalhorn
CA19-9: a pedictor of response in pancreatic cancer treated with gemcitabine and cisplatin.
Anticancer research 1999;19(4A):2433-5.
1997: HJ Krämling; N Willich; C Cramer; Ralf Wilkowski; Eckhart Dühmke; Friedrich W Schildberg
Early results of IORT in the treatment of gastric cancer.
Frontiers of radiation therapy and oncology 1997;31():157-60.
1997: J Grab; Johannes Zaspel; E Kallfass; Susanne Schultz-Hector; Ralf Wilkowski; W Doerr; HJ Krämling; Friedrich W Schildberg
Reactions of the gastric wall following IORT +/- ERT to the upper abdomen in rabbits.
Frontiers of radiation therapy and oncology 1997;31():47-50.
1997: HJ Krämling; J Grab; Johannes Zaspel; Susanne Schultz-Hector; E Kallfass; JC Kummermehr; Ralf Wilkowski; K Krimmel
Experimental study of vascular sequelae of combined upper abdominal intraoperative and external-beam radiation therapy.
Frontiers of radiation therapy and oncology 1997;31():36-40.
1997: Eva Neu; MC Michailov; Ralf Wilkowski; HJ Krämling; U Welscher; R Bischof; Eckhart Dühmke; N Willich; Friedrich W Schildberg
Implications of vasomotor reactions for a combined oncotherapy including IORT. II. Possibilities for adjuvant pharmacotherapy in oncotherapy.
Frontiers of radiation therapy and oncology 1997;31():28-31.
1997: MC Michailov; Eva Neu; U Welscher; N Willich; HJ Krämling; Ralf Wilkowski; J Foltinova; W Seidenbusch; Dieter Weiss
Implications of vasomotor reactions for a combined oncotherapy including IORT. I. Angiophysiology and oncotherapy.
Frontiers of radiation therapy and oncology 1997;31():22-7.
1996: Eckhart Dühmke; Volker Diehl; Markus Loeffler; R P Mueller; U Ruehl; Normann Willich; A Georgii; S Roth; D Matthaei; S Sehlen; O Brosteanu; Dirk Hasenclever; Ralf Wilkowski; K Becker
Randomized trial with early-stage Hodgkin's disease testing 30 Gy vs. 40 Gy extended field radiotherapy alone.
International journal of radiation oncology, biology, physics 1996;36(2):305-10.
1996: Susanne Schultz-Hector; P Brechenmacher; Wolfgang Dörr; J Grab; E Kallfass; K Krimmel; JC Kummermehr; M Sund; Ralf Wilkowski; Normann Willich; Johannes Zaspel; HJ Krämling
Complications of combined intraoperative radiation (IORT) and external radiation (ERT) of the upper abdomen: an experimental model.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1996;38(3):205-14.
1996: HJ Krämling; Ralf Wilkowski; Eckhart Dühmke; C Cramer; Normann Willich; F W Schildberg
[Adjuvant intraoperative radiotherapy of stomach carcinoma].
Langenbecks Archiv für Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress 1996;113():211-3.